Skip to main content


Mylan Confirms Availability of EpiPen Auto-Injector for U.S. Patients Affected by Sanofi's Auvi-Q Recall

Mylan Confirms Availability of EpiPen® (epinephrine injection) Auto-Injector for U.S. Patients Affected by Sanofi's Auvi-Q® (epinephrine injection, USP) Recall [Press Release]   HERTFORDSHIRE, England and PITTSBURGH, Oct. 29, 2015 /PRNewswire/ -- Mylan Specialty, a division of Mylan N.V. (Nasdaq: MYL ) which markets and distributes EpiPen ® (epinephrine injection) Auto-Injector, today commented on the voluntary nationwide recall of Sanofi's Auvi-Q ® (epinephrine...

Important Recall Notice: All Auvi-Q Epinephrine Auto-Injectors

Sanofi US Issues Voluntary Nationwide Recall of Auvi-Q ® Due to Potential Inaccurate Dosage Delivery   [Press Release]   Company Contact Karen Sutherland Tel. : +1 908-989-0726 Email :     Bridgewater, N.J. - October 30, 2015 - Sanofi US is voluntarily recalling all Auvi-Q® (epinephrine injection, USP).The recall involves all Auvi-Q currently on the market and includes both the 0.15 mg and 0.3 mg strengths for hospitals,...

Milk Allergy Alert - David Trail Mix Sweet and Salty Flavor

David Trail Mix Sweet & Salty Voluntarily Recalled Due To Undeclared Dairy Allergen FDA posts press releases and other notices of recalls and market withdrawals from the firms involved as a service to consumers, the media, and other interested parties. FDA does not endorse either the product or the company. For Immediate Release October 24, 2015 Contact Consumers Consumer Affairs Hotline (800) 881-3989 Media Monique Farmer ...

Kids With Food Allergies
A Division of the Asthma and Allergy Foundation of America
1235 South Clark Street Suite 305, Arlington, VA 22202
Phone: 1-800-7-ASTHMA (1.800.727.8462)